Shares of CYRX stock opened at $18.70 on Monday. The company has a market cap of $573.64 million, a price-to-earnings ratio of -60.32 and a beta of 0.84. The company has a debt-to-equity ratio of 0.42, a quick ratio of 11.52 and a current ratio of 11.57. CryoPort has a fifty-two week low of $8.28 and a fifty-two week high of $19.20.
CryoPort (NASDAQ:CYRX) last announced its quarterly earnings results on Thursday, May 2nd. The consumer goods maker reported ($0.08) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.08). The firm had revenue of $6.65 million for the quarter, compared to analysts’ expectations of $6.56 million. CryoPort had a negative net margin of 41.61% and a negative return on equity of 28.30%. CryoPort’s revenue was up 65.4% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.10) earnings per share. As a group, equities research analysts anticipate that CryoPort will post -0.29 earnings per share for the current fiscal year.
CryoPort, Inc engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers.
Recommended Story: Cost of Goods Sold (COGS)
Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.